Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06157164 · ClinicalTrials.gov registry record
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
A clinical trial, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- 3
- Enrollment target
NCT06157164 is a clinical trial that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT06157164 was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
Interventions
- OTHER UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2025-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06157164
The ClinicalTrials.gov registry entry for NCT06157164 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP) is the first listed.
NCT06157164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06157164 about?
NCT06157164 is a clinical study titled "IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation". To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
What is the current status of trial NCT06157164?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2023-02-06. Estimated completion is 2025-01-14.
What interventions are being tested in trial NCT06157164?
The interventions under investigation include: UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP) (OTHER).
Who is sponsoring clinical trial NCT06157164?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.